Testing and Evaluation of Placebo Effects for Chinese Herbal Medicine FYTF-919
Status:
Not yet recruiting
Trial end date:
2023-03-31
Target enrollment:
Participant gender:
Summary
TCM is an essential context of the ICH management in Chinese culture. Given the potential
benefits of Chinese herbal medicine FYTF-919 in reducing haematoma and bleeding after acute
ICH from fundamental research and small clinical studies, more reliable evidence is required
to guide ICH treatment using TCM. This study is based on manual scoring and intelligent
sensory technology scoring methods, which are used to compare physical consistency between
preparation of FYTF-919 and its placebo, simultaneously the two drugs are evaluated in a
blinded way. Therefore, the efficacy of placebo preparation of FYTF-919 and feasibility of
its application in randomized, double-blind, placebo-controlled clinical trials will be
obtained.
Phase:
Phase 3
Details
Lead Sponsor:
Guangzhou University of Traditional Chinese Medicine